Anthropic is enhancing Claude, a sophisticated AI model, to support a comprehensive range of tasks in the life sciences, from discovery to commercialization, aiming to speed up scientific progress. The improved Claude Sonnet 4.5 model outperforms previous iterations in understanding laboratory protocols and bioinformatics tasks, while new connectors and Agent Skills extend its functionality across scientific platforms like Benchling, BioRender, and PubMed. These enhancements are designed to assist researchers, clinical coordinators, and regulatory managers by enabling Claude to conduct literature reviews, generate study protocols, analyze genomic data, and ensure regulatory compliance. The initiative includes partnerships with industry leaders such as Caylent, Deloitte, and Google Cloud, and offers dedicated support and prompt libraries to optimize Claude's utility in scientific workflows. By integrating Claude across various platforms, companies like Sanofi and AbbVie have reported improvements in efficiency and innovation, highlighting Claude's role in transforming research and development processes. Additionally, Anthropic's AI for Science program provides free API credits to support high-impact research projects, further cementing Claude's position as a pivotal tool in life sciences.